BREAKING: TX Gov. Abbott Circumventing Biden On Monoclonal Antibodies; Border; Federal Govt
September 27, 2021
646
87
12
15.33%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Dana Loesch Episodes Around September 27, 2021
See what was published immediately before and after this episode.
13:26Now PlayingBREAKING: TX Gov. Abbott Circumventing Biden On Monoclonal Antibodies; Border; Federal Govt
YouTube Description
as posted by the channelDana (@DLoesch) talks with TX Governor Greg Abbott (@GovAbbott) on bypassing the Biden administration by purchasing those life-saving monoclonal antibody treatments directly, instead of dealing with the Biden administration’s politicizing it, and restricting it to TX and other red states. Texans now do not have to worry about any restrictions or shortfalls as it relates to this treatment, thanks to the actions by the Governor.
The southern border, and the failings of the Federal Government with illegal migration is discussed. There have been legal channels that Governor Abbott has used in order to hold the Biden Administration accountable for their failings at the border, and the Biden administration is fighting Gov. Abbott on all of it.
Broadcast terrestrially coast to coast, stream, podcasted, one of the top 10 radio programs in the nation. Listen to Dana LIVE weekdays
Subscribe to the Chapter and Verse newsletter
Twitter: @DLoesch
Parler: @DanaLoesch
FB: @OfficialDanaLoesch
Instagram: @DLoesch
Links & Promotions
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.









